Giovanna Cassone Salata
Overview
Explore the profile of Giovanna Cassone Salata including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
39
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Passos J, Dartora V, Cassone Salata G, Draszesski Malago I, Lopes L
Int J Pharm
. 2023 Feb;
635:122681.
PMID: 36738808
Breast cancer is a major public health problem, affecting millions of people. It is a very heterogeneous disease, with localized and invasive forms, and treatment generally consists of a combination...
2.
Donadon L, Cassone Salata G, Goncalves T, Matos L, Evangelista M, da Silva N, et al.
Int J Pharm
. 2023 Jan;
633:122612.
PMID: 36642349
This study evaluated the potential of monoolein (MO)-based nanodispersions to promote the cutaneous co-delivery of metformin (MET) and methylene blue (MB) for the treatment of non-melanoma skin cancer. MO-based nanodispersions...
3.
Cassone Salata G, Lopes L
Pharmaceuticals (Basel)
. 2022 Sep;
15(9).
PMID: 36145331
In this study, incorporation of the cytotoxic agent paclitaxel and the P-glycoprotein inhibitor elacridar in hyaluronic acid (HA)-modified nanoemulsions was studied for intraductal delivery and breast cancer localized treatment. To...
4.
Apolinario A, Cassone Salata G, de Souza M, Chorilli M, Lopes L
AAPS PharmSciTech
. 2022 Apr;
23(4):104.
PMID: 35381947
Herein, we developed an ethosomal hydrogel based on three types of ethosomes: simple, mixed (surfactant-based micelles and lipid vesicles) or binary (comprising two type of alcohols). Ethanol injection was employed...
5.
Cassone Salata G, Malago I, Carvalho Dartora V, Pessoa A, Fantini M, Costa S, et al.
Mol Pharm
. 2021 Sep;
18(9):3401-3417.
PMID: 34482696
The need of pharmacological strategies to preclude breast cancer development motivated us to develop a non-aqueous microemulsion (ME) capable of forming a depot after administration in the mammary tissue and...
6.
de Bastiani F, de Castro Spadari C, de Matos J, Cassone Salata G, Lopes L, Ishida K
Front Microbiol
. 2020 Jan;
10:2976.
PMID: 31998264
Topical drug administration is frequently used for the treatment of vaginal candidiasis; however, most formulations using this route do not provide prolonged drug release. Our aim was to evaluate the...
7.
Cassone Salata G, Pinho C, de Freitas A, Aquino A, Justulin L, Mendes L, et al.
J Pharm Pharmacol
. 2019 Mar;
71(7):1065-1071.
PMID: 30919959
Objectives: This study evaluated raloxifene (ral) effects on LNCaP prostate tumour cells modulating the activity of GPER1/GPR30 receptors. Methods: LNCaP cells were submitted for 40/120 min and 12 h to...
8.
Garcia M, Goncalves T, Sao Felix Martins E, Martins T, Fantini M, Regazi Minarini P, et al.
Int J Pharm
. 2018 Jul;
548(1):454-465.
PMID: 30018009
The purpose of this study was to evaluate the effect of composition and characteristics of liquid crystalline phases (LCPs) on cutaneous delivery of methylene blue (MB). LCPs were obtained by...